Many sectors of Chinese society mourned the death of renowned Hong Kong philanthropist and prominent industrialist Tin Ka-ping, who died at the age of 99 in the city on Tuesday morning.Leading the tributes was the central government's top representative in Hong Kong, Wang Zhiming, director of the Liaison Office of the Central People's Government in the Hong Kong Special Administrative Region. Wang expressed his sorrow over Tin's death on Wednesday.He said he respected and appreciated Tin's lifelong love for the country and his great contribution to education in China.Tin cared about society and promoted public welfare in ways that will benefit future generations, Wang said.Joining him was Hong Kong's Chief Executive Carrie Lam Cheng Yuet-ngor. She said on Tuesday that Tin not only made significant contributions to the industrial development of Hong Kong but was also devoted to philanthropy over the past few decades, both in the special administrative region and on the mainland.Lam said she was grieved to learn of Tin's passing and extended condolences to his family.Hong Kong's Secretary for Education Kevin Yeung Yunhung said the Tin Ka Ping Foundation funded various educational institutions, from kindergartens to universities, as well as several scholarship and exchange programs that benefit a large number of local students.Born in Guangdong province, Tin moved to Hong Kong in 1958. He was successful in his early days in the chemicals business and later made a fortune in real estate. He devoted his life to promoting the development of charities, donating 80 percent of his total assets to different fields, especially education.So far, the foundation, a nonprofit charity founded by Tin in 1982, has funded 318 education institutions, more than 1,800 rural libraries, 29 hospitals and about 130 bridges and roads across 34 provinces, municipalities and autonomous regions in China.Educational institutions that were funded by Tin in both Hong Kong and the mainland also expressed both sorrow and appreciation.The University of Hong Kong said that Tin was a selfless educator and philanthropist who had contributed immensely to the development of teaching, learning and research in Hong Kong and on the mainland.Zhejiang University posted a tribute to Tin on its social media account. Tin provided money to establish the Tin Ka Ping Academy on the Xixi campus of the university. As it is the place where most students go for classes, the building bears witness to students' growth, the university said.Tin's name and the building have been integrated into the university, the post said.Other universities and middle schools in different provinces, including Guangdong, Sichuan, Yunnan, Jiangsu, also mourned Tin. All of them have received donations. design your own wristbandsilicone bracelet makerprinted bracelets24 hour wristbands
BEIJING -- China is working to reduce the prices of cancer drugs and the financial burden on patients, according to health officials Saturday. Prices of cancer drugs will be reduced through centralized negotiations and procurement, Zeng Yixin, vice director of the National Health Commission, said at a press conference. According to Chen Jinfu, head of the medical insurance department of the Ministry of Human Resources and Social Security, last year the government reached agreements with pharmaceutical enterprises on the prices of 36 cancer medicines on the medical insurance list. Prices of these drugs have been marked down by 44 percent on average, Chen said. Stressing a patient-centered approach in negotiations, the official also noted that market competition is also needed. The government will work to include more antineoplastic drugs into the country's catalogue of medical insurance reimbursement, which already incorporates most of the relevant drugs. Moreover, efforts have been made in accelerating the review and approval procedures for new medicines, reducing circulation costs and improving diagnosis to reduce the burden on patients and their families, Zeng said. The average approval time for imported drugs has been significantly shortened, and the customs clearance procedures streamlined, said Li Jinju, an official with China Food and Drug Administration. The Ministry of Finance announced Monday that China will exempt 28 drugs from import tariffs, including all cancer drugs from May 1, as part of wider opening of the market. Admitting that the tariff cut may challenge China's domestic pharmaceutical industry, Liu Dengfeng of the health commission expressed confidence in tackling it. China's medical research and development has progressed in recent years with the talent pool getting stronger and innovation booming, he said.
